Tovecimig Clinical Trials (2026): 1 Studies for Colorectal Cancer & Metastatic Colorectal Cancer
Hipa.ai Research · Source: ClinicalTrials.gov / AACT
Synced daily from ClinicalTrials.gov via AACT. Last sync: .
1 Tovecimig clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 1 indication (including Colorectal Cancer & Metastatic Colorectal Cancer) and 25 total planned enrollment. 1 Tovecimig clinical trial is actively recruiting. Most recent activity: NCT07662031 (Aug 2032).
Tovecimig clinical trials at a glance: phase × recruitment status
| Phase | not yet recruiting | Total |
|---|---|---|
| P2 | 1 | 1 |
Recruiting Tovecimig clinical trials (1)
Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).
| NCT ID | Title | Phase | Indication | Enrollment | Started |
|---|---|---|---|---|---|
| NCT07662031 | Tovecimig Plus FOLFIRI in Second Line Metastatic Colorectal Cancer | P2 | Colorectal Cancer | 25 | Aug 2026 |
All Tovecimig trials (1)
Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.
| NCT ID | Acronym | Title | Phase | Status | Enrollment | Sponsor | Started |
|---|---|---|---|---|---|---|---|
| NCT07662031 | Tovecimig Plus FOLFIRI in Second Line Metastatic Colorectal Cancer | P2 | not yet recruiting | 25 | Washington University School of Medicine | Aug 2026 |
Tovecimig clinical trials: frequently asked questions
- How many Tovecimig clinical trials are there?
- 1 Tovecimig clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov.
- Are Tovecimig clinical trials recruiting in 2026?
- No active Tovecimig trials are recruiting on ClinicalTrials.gov as of the current AACT refresh. Trials may resume; this page is updated daily.
- What conditions is Tovecimig being studied for?
- Tovecimig is being studied for Colorectal Cancer, Metastatic Colorectal Cancer. The trials are grouped by indication on this page.
- What phase is Tovecimig in?
- Tovecimig clinical trials span 1 Phase 2. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
- Who sponsors Tovecimig clinical trials?
- The lead sponsor across the most Tovecimig trials is Washington University School of Medicine. Each trial row links to the full study detail page including sponsor information.
Sources and methodology
Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming Tovecimigas an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.
Last refreshed .
Related pages on Hipa.ai: